XML 59 R47.htm IDEA: XBRL DOCUMENT v3.19.1
Investment in Surface Pharmaceuticals, Inc. and Agreements - Related Party Transactions (Details Narrative) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Jan. 31, 2018
Mar. 31, 2019
Surface Pharmaceuticals Inc [Member]    
Number of shares owned   3,500,000
Ownership percentage   30.00%
Surface Pharmaceuticals Inc [Member] | Dr. Lindstrom [Member]    
Royalty payment percentage on net sales   3.00%
Surface License Agreements [Member]    
Royalty payment description   Surface is required to make royalty payments to the Company of four to six percent (4%-6%) of net sales of the Surface Products while any patent rights remain outstanding.
Management Services Agreement [Member] | Surface Pharmaceuticals Inc [Member]    
Administrative expenses $ 10  
Reimbursable expenses due   $ 50